Immunophenotype of CAR T-cells and associated apheresis products predicts clinical response in a single-center CD22 CAR T-cell therapy trial in B-cell acute lymphoblastic leukemia
Alexandra Dreyzin,Lipei Shao,Yihua Cai,Kyu Lee Han,Michaela Procházková,Michael Gertz,Bonnie Yates,Rongye Shi,Kathryn A. Martin,Naomi Taylor,Steven L. Highfill,Maura O’Neill,Þorkell Andrésson,David F. Stroncek,Ping Jin,Nirali N. Shah